GlycoVaxyn's technology paves the way for synthesizing bioconjugate material to levels previously unattainable and in a more cost-effective manner. |
GlycoVaxyn will be attending: - the VacChina Vaccine Development Summit in Shanghai, China on September 15-16, 2010 GlycoVaxyn will be PRESENTING at: - the Sofinnova Japan Biopharma Partnering Conference in Tokyo, Japan on September 28, 2010 - the 10th Annual Biotech in Europe Investor Forum in Zurich, Switzerland on September 29-30, 2010 - the World Vaccine Congress taking place in Lyon, France on October 4-7, 2010 |